Gina Novo Nordisk - Search News

Novo Nordisk upgraded to Buy from Neutral at UBS

Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock to "buy" from "neutral," calling the recent sell-off of the stock "overdone.

Business Insider · 2d

Novo Nordisk upgraded to Buy from Neutral at UBS, as CagriSema selloff overdone

UBS analyst upgraded Novo Nordisk (NVO) to Buy from Neutral with a price target of DKK 750, down from DKK 1,100. Novo Nordisk is “well placed”

Zacks.com on MSN · 20h

NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy

Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from “Neutral” to “Buy.” Novo Nordisk markets its semaglutide medicines as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes (T2D) and Wegovy injection for weight management.

Novo Nordisk Expands AI Partnership With Valo Health

GEN · 1d

Novo Nordisk, Valo Health Ink Expanded Up-to-$4.6B AI Collaboration

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial intelligence (AI) partnership aimed at discovering and developing up to 20 treatments for obesity,

U.S. News & World Report · 1d

Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs

Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

Seeking Alpha on MSN · 1d

Novo Nordisk, Valo Health expand drug discovery deal

Danish drugmaker Novo Nordisk (NVO) (OTCPK:NONOF) and AI-focused biotech Valo Health announced Wednesday an agreement to expand their existing collaboration to discover and develop new treatments targeting cardiometabolic diseases.

Becker's Hospital Review1d

Novo Nordisk joins Eli Lilly in legal challenge over GLP-1 compounding

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...

Yahoo Finance24d

Novo Nordisk invests $1.2bn in new Denmark facility

Denmark-based pharma giant Novo Nordisk has announced plans to invest DKr8.5bn ($1.2bn) to establish a new production facility in Odense, Denmark. Announcing the news yesterday (16 December), the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Novo Nordisk upgraded to Buy from Neutral at UBS

Novo Nordisk Expands AI Partnership With Valo Health

Trending now